EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond the Muscle–Kidney Paradigm: Liver–Muscle–Kidney Interactions in Rhabdomyolysis

Xiangyi Zhou, Hongbing Deng, Fachun Zhou, Zhihui Tong, Daqian Gu

Life · 31.10.2026 · 16 (11) · 1852

DOI: 10.3390/life16111852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 31.10.2026. Verfasst von Xiangyi Zhou und 4 weiteren Autor:innen. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Chongqing, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyolysis is classically understood as skeletal muscle injury complicated by myoglobin-mediated acute kidney injury, but this framework does not fully explain the diagnostic and clinical complexity created by liver disease, aminotransferase abnormalities, and multiorgan dysfunction. This narrative review summarizes clinical and experimental evidence on liver, muscle, and kidney interactions in rhabdomyolysis. Relevant studies addressing aminotransferase elevation, liver-related susceptibility to muscle injury, rhabdomyolysis-associated kidney injury, interorgan communication, and shared systemic insults were reviewed. The evidence indicates that aminotransferase elevation in rhabdomyolysis often reflects muscle injury rather than primary hepatic damage, requiring interpretation with serial enzyme trends, liver-specific markers, and clinical context. Liver disease may increase vulnerability to muscle injury and kidney injury through sarcopenia, metabolic disturbance, altered drug handling, and impaired perfusion. Severe rhabdomyolysis may also contribute to hepatic stress through inflammation, heme-related pathways, and AKI-mediated effects, although direct causal evidence remains limited. A liver–muscle–kidney framework may improve integrated assessment, but prospective studies are needed to clarify temporal relationships and validate clinically useful biomarkers.

Förderung

  • Science and Technology Commission of Chongqing
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, X., Deng, H., Zhou, F., Tong, Z., & Gu, D. (2026). Beyond the Muscle–Kidney Paradigm: Liver–Muscle–Kidney Interactions in Rhabdomyolysis. Life, 16(11), 1852. https://doi.org/10.3390/life16111852

Vancouver

Zhou X, Deng H, Zhou F, Tong Z, Gu D. Beyond the Muscle–Kidney Paradigm: Liver–Muscle–Kidney Interactions in Rhabdomyolysis. Life. 2026;16(11):1852. doi:10.3390/life16111852

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiangyi and Deng, Hongbing and Zhou, Fachun and Tong, Zhihui and Gu, Daqian},
  title = {Beyond the Muscle–Kidney Paradigm: Liver–Muscle–Kidney Interactions in Rhabdomyolysis},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1852},
  doi = {10.3390/life16111852}
}
Kostenlos starten →